nodes	percent_of_prediction	percent_of_DWPC	metapath
Diphenidol—Dyclonine—SCN10A—melanoma	0.0442	0.566	CrCbGaD
Diphenidol—Clotrimazole—CYP17A1—melanoma	0.0135	0.172	CrCbGaD
Diphenidol—Biperiden—ABCB1—melanoma	0.00572	0.0732	CrCbGaD
Diphenidol—Fexofenadine—ABCB1—melanoma	0.00347	0.0444	CrCbGaD
Diphenidol—Clotrimazole—ABCB1—melanoma	0.00268	0.0343	CrCbGaD
Diphenidol—Bepridil—ABCB1—melanoma	0.00249	0.0319	CrCbGaD
Diphenidol—Fentanyl—ABCB1—melanoma	0.00229	0.0293	CrCbGaD
Diphenidol—Loperamide—ABCB1—melanoma	0.00221	0.0282	CrCbGaD
Diphenidol—Methadone—ABCB1—melanoma	0.00157	0.0201	CrCbGaD
Diphenidol—CHRM3—Signaling Pathways—SYK—melanoma	0.000302	0.000328	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CD—melanoma	0.000301	0.000326	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CD—melanoma	0.0003	0.000325	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SYK—melanoma	0.000299	0.000324	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ITGAV—melanoma	0.000297	0.000323	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT3—melanoma	0.000297	0.000323	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NGFR—melanoma	0.000297	0.000323	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CD—melanoma	0.000297	0.000322	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NGFR—melanoma	0.000296	0.000322	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ITGAV—melanoma	0.000296	0.000322	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT3—melanoma	0.000296	0.000322	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT3—melanoma	0.000294	0.000319	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ITGAV—melanoma	0.000294	0.000319	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NGFR—melanoma	0.000294	0.000319	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PRKCA—melanoma	0.000279	0.000303	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ERCC2—melanoma	0.000277	0.0003	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SOCS1—melanoma	0.000275	0.000299	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—MAP2K1—melanoma	0.000275	0.000298	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—S100B—melanoma	0.000275	0.000298	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SOCS1—melanoma	0.000275	0.000298	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—MAP2K1—melanoma	0.000274	0.000297	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—S100B—melanoma	0.000274	0.000297	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CD—melanoma	0.000273	0.000296	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CD—melanoma	0.000272	0.000295	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SOCS1—melanoma	0.000272	0.000295	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MAP2K1—melanoma	0.000271	0.000294	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—S100B—melanoma	0.000271	0.000294	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CD—melanoma	0.000269	0.000292	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ERBB4—melanoma	0.000263	0.000285	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CB—melanoma	0.000262	0.000284	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ERBB4—melanoma	0.000262	0.000284	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CB—melanoma	0.000261	0.000283	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN2B—melanoma	0.00026	0.000283	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN2B—melanoma	0.00026	0.000282	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ERBB4—melanoma	0.000259	0.000281	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CB—melanoma	0.000259	0.000281	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN2B—melanoma	0.000257	0.000279	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CD86—melanoma	0.000252	0.000273	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—CXCL8—melanoma	0.000252	0.000273	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CD86—melanoma	0.000251	0.000272	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—CXCL8—melanoma	0.000251	0.000272	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EDN1—melanoma	0.00025	0.000271	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EDN1—melanoma	0.000249	0.00027	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CD86—melanoma	0.000249	0.00027	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—CXCL8—melanoma	0.000249	0.00027	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EDN1—melanoma	0.000247	0.000268	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CSF2—melanoma	0.000244	0.000265	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF1—melanoma	0.000244	0.000265	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CSF2—melanoma	0.000243	0.000264	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF1—melanoma	0.000243	0.000264	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CSF2—melanoma	0.000241	0.000262	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF1—melanoma	0.000241	0.000262	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—IL2—melanoma	0.000241	0.000261	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—IL2—melanoma	0.00024	0.00026	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—E2F1—melanoma	0.000239	0.000259	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—E2F1—melanoma	0.000238	0.000258	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CB—melanoma	0.000238	0.000258	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—IL2—melanoma	0.000238	0.000258	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CB—melanoma	0.000237	0.000257	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PDGFRA—melanoma	0.000237	0.000257	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—E2F1—melanoma	0.000236	0.000256	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PDGFRA—melanoma	0.000236	0.000256	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CB—melanoma	0.000235	0.000255	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ITGB3—melanoma	0.000234	0.000254	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PRKCA—melanoma	0.000234	0.000254	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PDGFRA—melanoma	0.000234	0.000253	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PRKCA—melanoma	0.000233	0.000253	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ITGB3—melanoma	0.000233	0.000253	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ITGB3—melanoma	0.000231	0.000251	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PRKCA—melanoma	0.000231	0.000251	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—SPP1—melanoma	0.00023	0.000249	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAP2K2—melanoma	0.000229	0.000248	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—SPP1—melanoma	0.000229	0.000248	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—CXCL8—melanoma	0.000229	0.000248	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAP2K2—melanoma	0.000228	0.000248	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—CXCL8—melanoma	0.000228	0.000247	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—SPP1—melanoma	0.000227	0.000246	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAP2K2—melanoma	0.000226	0.000245	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—CXCL8—melanoma	0.000226	0.000245	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CG—melanoma	0.000219	0.000237	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL2—melanoma	0.000219	0.000237	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL2—melanoma	0.000218	0.000236	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TERT—melanoma	0.000218	0.000236	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—RAC1—melanoma	0.000217	0.000236	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TERT—melanoma	0.000217	0.000235	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—RAC1—melanoma	0.000216	0.000235	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL2—melanoma	0.000216	0.000234	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TERT—melanoma	0.000215	0.000233	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—RAC1—melanoma	0.000214	0.000232	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PPARG—melanoma	0.000211	0.000229	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HIF1A—melanoma	0.000208	0.000226	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HIF1A—melanoma	0.000208	0.000225	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HIF1A—melanoma	0.000206	0.000223	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KDR—melanoma	0.000199	0.000216	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KDR—melanoma	0.000198	0.000215	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KDR—melanoma	0.000197	0.000213	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CD—melanoma	0.000192	0.000209	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FN1—melanoma	0.000192	0.000208	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FN1—melanoma	0.000191	0.000207	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—ALB—melanoma	0.00019	0.000206	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FN1—melanoma	0.000189	0.000205	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NOTCH1—melanoma	0.000188	0.000203	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NOTCH1—melanoma	0.000187	0.000203	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NOTCH1—melanoma	0.000185	0.000201	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CD80—melanoma	0.000184	0.000199	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KIT—melanoma	0.000183	0.000199	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—APC—melanoma	0.000183	0.000199	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CG—melanoma	0.000183	0.000199	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—NRAS—melanoma	0.000183	0.000199	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CD80—melanoma	0.000183	0.000199	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KIT—melanoma	0.000183	0.000198	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—APC—melanoma	0.000183	0.000198	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CG—melanoma	0.000183	0.000198	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—NRAS—melanoma	0.000183	0.000198	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CD80—melanoma	0.000181	0.000197	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGF—melanoma	0.000181	0.000197	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CG—melanoma	0.000181	0.000196	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KIT—melanoma	0.000181	0.000196	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—APC—melanoma	0.000181	0.000196	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—NRAS—melanoma	0.000181	0.000196	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGF—melanoma	0.000181	0.000196	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGF—melanoma	0.000179	0.000194	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—MAPK3—melanoma	0.000176	0.000191	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—MAPK3—melanoma	0.000175	0.00019	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MAPK3—melanoma	0.000173	0.000188	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—BRAF—melanoma	0.000172	0.000187	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—BRAF—melanoma	0.000172	0.000186	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—BRAF—melanoma	0.00017	0.000185	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IGF1—melanoma	0.000168	0.000182	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CB—melanoma	0.000168	0.000182	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IGF1—melanoma	0.000167	0.000182	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—MAPK1—melanoma	0.000167	0.000181	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—EGFR—melanoma	0.000167	0.000181	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—MAPK1—melanoma	0.000167	0.000181	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—EGFR—melanoma	0.000167	0.000181	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTGS2—melanoma	0.000166	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IGF1—melanoma	0.000166	0.00018	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—MAPK1—melanoma	0.000165	0.000179	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—EGFR—melanoma	0.000165	0.000179	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAP2K1—melanoma	0.000162	0.000176	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAP2K1—melanoma	0.000162	0.000176	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CD—melanoma	0.000161	0.000175	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CD—melanoma	0.000161	0.000174	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAP2K1—melanoma	0.00016	0.000174	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	0.00016	0.000173	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	0.000159	0.000173	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CD—melanoma	0.000159	0.000173	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—KRAS—melanoma	0.000158	0.000171	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	0.000158	0.000171	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—KRAS—melanoma	0.000157	0.000171	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—KRAS—melanoma	0.000156	0.000169	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—FGF2—melanoma	0.000154	0.000167	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—FGF2—melanoma	0.000154	0.000167	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—FGF2—melanoma	0.000152	0.000165	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—PIK3CA—melanoma	0.000145	0.000157	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PTEN—melanoma	0.000145	0.000157	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—PIK3CA—melanoma	0.000145	0.000157	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MDM2—melanoma	0.000144	0.000157	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MDM2—melanoma	0.000144	0.000156	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—PIK3CA—melanoma	0.000143	0.000155	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MDM2—melanoma	0.000143	0.000155	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—ERBB2—melanoma	0.000142	0.000154	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—ERBB2—melanoma	0.000142	0.000154	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—ERBB2—melanoma	0.000141	0.000153	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CB—melanoma	0.000141	0.000152	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CB—melanoma	0.00014	0.000152	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CB—melanoma	0.000139	0.000151	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CXCL8—melanoma	0.000135	0.000147	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CXCL8—melanoma	0.000135	0.000146	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—HRAS—melanoma	0.000134	0.000146	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—HRAS—melanoma	0.000134	0.000145	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CXCL8—melanoma	0.000133	0.000145	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—HRAS—melanoma	0.000132	0.000144	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN1B—melanoma	0.000132	0.000143	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN1B—melanoma	0.000131	0.000143	CbGpPWpGaD
Diphenidol—CHRM1—GPCR downstream signaling—AKT1—melanoma	0.00013	0.000142	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN1B—melanoma	0.00013	0.000141	CbGpPWpGaD
Diphenidol—CHRM3—GPCR downstream signaling—AKT1—melanoma	0.00013	0.000141	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CASP3—melanoma	0.000129	0.00014	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL2—melanoma	0.000129	0.00014	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CASP3—melanoma	0.000129	0.00014	CbGpPWpGaD
Diphenidol—CHRM2—GPCR downstream signaling—AKT1—melanoma	0.000129	0.00014	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL2—melanoma	0.000129	0.00014	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—IL6—melanoma	0.000128	0.000139	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—IL6—melanoma	0.000128	0.000139	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CASP3—melanoma	0.000128	0.000138	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL2—melanoma	0.000127	0.000138	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—IL6—melanoma	0.000127	0.000138	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CCND1—melanoma	0.000126	0.000136	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CCND1—melanoma	0.000125	0.000136	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CTNNB1—melanoma	0.000125	0.000135	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CCND1—melanoma	0.000124	0.000135	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CTNNB1—melanoma	0.000124	0.000135	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CTNNB1—melanoma	0.000123	0.000133	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MMP9—melanoma	0.000122	0.000133	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MMP9—melanoma	0.000122	0.000132	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—CDKN1A—melanoma	0.000122	0.000132	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PTEN—melanoma	0.000121	0.000132	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—CDKN1A—melanoma	0.000121	0.000132	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PTEN—melanoma	0.000121	0.000131	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NFKB1—melanoma	0.000121	0.000131	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MMP9—melanoma	0.000121	0.000131	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NFKB1—melanoma	0.00012	0.000131	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—CDKN1A—melanoma	0.00012	0.00013	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PTEN—melanoma	0.00012	0.00013	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NFKB1—melanoma	0.000119	0.000129	CbGpPWpGaD
Diphenidol—CHRM1—Signaling by GPCR—AKT1—melanoma	0.000118	0.000129	CbGpPWpGaD
Diphenidol—CHRM3—Signaling by GPCR—AKT1—melanoma	0.000118	0.000128	CbGpPWpGaD
Diphenidol—CHRM2—Signaling by GPCR—AKT1—melanoma	0.000117	0.000127	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—VEGFA—melanoma	0.00011	0.000119	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—VEGFA—melanoma	0.000109	0.000119	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—STAT3—melanoma	0.000109	0.000118	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—NRAS—melanoma	0.000108	0.000118	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—VEGFA—melanoma	0.000108	0.000117	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—STAT3—melanoma	0.000108	0.000117	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—NRAS—melanoma	0.000108	0.000117	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—STAT3—melanoma	0.000107	0.000116	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—NRAS—melanoma	0.000107	0.000116	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK3—melanoma	0.000104	0.000113	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK3—melanoma	0.000103	0.000112	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK3—melanoma	0.000102	0.000111	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—PIK3CA—melanoma	0.000102	0.000111	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MYC—melanoma	0.000101	0.000109	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MYC—melanoma	0.000101	0.000109	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MYC—melanoma	9.96e-05	0.000108	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—MAPK1—melanoma	9.87e-05	0.000107	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—EGFR—melanoma	9.87e-05	0.000107	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—MAPK1—melanoma	9.84e-05	0.000107	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—EGFR—melanoma	9.84e-05	0.000107	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—MAPK1—melanoma	9.75e-05	0.000106	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—EGFR—melanoma	9.75e-05	0.000106	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—KRAS—melanoma	9.33e-05	0.000101	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—KRAS—melanoma	9.3e-05	0.000101	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—KRAS—melanoma	9.21e-05	9.99e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—PIK3CA—melanoma	8.57e-05	9.29e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—PIK3CA—melanoma	8.54e-05	9.26e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—PIK3CA—melanoma	8.46e-05	9.17e-05	CbGpPWpGaD
Diphenidol—CHRM3—Metabolism—AKT1—melanoma	8.34e-05	9.05e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—TP53—melanoma	8.29e-05	8.99e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—TP53—melanoma	8.26e-05	8.96e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—TP53—melanoma	8.18e-05	8.88e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—HRAS—melanoma	7.93e-05	8.6e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—HRAS—melanoma	7.9e-05	8.57e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—HRAS—melanoma	7.83e-05	8.49e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—IL6—melanoma	7.59e-05	8.23e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—IL6—melanoma	7.56e-05	8.2e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—IL6—melanoma	7.49e-05	8.12e-05	CbGpPWpGaD
Diphenidol—CHRM1—Signaling Pathways—AKT1—melanoma	7e-05	7.59e-05	CbGpPWpGaD
Diphenidol—CHRM3—Signaling Pathways—AKT1—melanoma	6.98e-05	7.57e-05	CbGpPWpGaD
Diphenidol—CHRM2—Signaling Pathways—AKT1—melanoma	6.91e-05	7.5e-05	CbGpPWpGaD
